Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial

Show other versions (1)

Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody responses and vaccine effectiveness are sustained in adolescents, in contrast to rapid waning in young children. We investigated the persistence of serum bactericidal antibody (SBA) titers in children 6...

Full description

Bibliographic Details
Main Authors:	Perrett, K, Winter, A, Kibwana, E, Jin, C, John, T, Yu, L, Borrow, R, Curtis, N, Pollard, A
Other Authors:	Infectious Diseases Society of America
Format:	Journal article
Language:	English
Published:	University of Chicago Press 2010
Subjects:	Paediatrics Vaccinology

Similar Items

Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.
by: Perrett, K, et al.
Published: (2010)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
by: Snape, M, et al.
Published: (2006)

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
by: Riddell, A, et al.
Published: (2007)

Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
by: Pollard, A, et al.
Published: (2009)

Vaccine prevention of meningococcal disease, coming soon?
by: Morley, S, et al.
Published: (2001)

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
by: Pulickal, A, et al.
Published: (2007)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
by: Snape, M, et al.
Published: (2008)

Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
by: Collins, C, et al.
Published: (2004)

Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization
by: Vu, D, et al.
Published: (2006)

Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal
by: Pulickal, A, et al.
Published: (2009)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
by: Clutterbuck, E, et al.
Published: (2006)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
by: Blanchard-Rohner, G, et al.
Published: (2010)

Sustaining immunity after immunization against encapsulated bacteria
by: Blanchard-Rohner, G, et al.
Published: (2008)

Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria
by: Sadarangani, M, et al.
Published: (2011)

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
by: Pace, D, et al.
Published: (2008)

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
by: Perrett, K, et al.
Published: (2012)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01)

Vaccines against bacterial meningitis
by: Segal, S, et al.
Published: (2004)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
by: Diggle, L, et al.
Published: (2006)

Global epidemiology of meningococcal disease and vaccine efficacy
by: Pollard, A
Published: (2004)

School-aged children: a reservoir for continued circulation of Haemophilus influenzae Type b in the United Kingdom
by: Oh, S, et al.
Published: (2008)

B cell responses to conjugate and polysaccharide meningococcal vaccines
by: Ramasamy, M
Published: (2012)

What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
by: Scott, J, et al.
Published: (2008)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
by: Lee, Y, et al.
Published: (2006)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.
by: Snape, MD, et al.
Published: (2008)

Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017-05-01)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
by: de Whalley, P, et al.
Published: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
by: De Whalley, P, et al.
Published: (2013)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
by: Pollard, A, et al.
Published: (2004)

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
by: Pace, D, et al.
Published: (2007)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
by: Lee, Y, et al.
Published: (2008)

Emergency management of meningococcal disease: eight years on
by: Pollard, A, et al.
Published: (2007)

Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014)

Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.
by: Perrett, K, et al.
Published: (2014)

Public policy for meningococcal vaccination
by: J. Claire Cameron
Published: (2018-05-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
by: Blanchard-Rohner, G, et al.
Published: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
by: Blanchard-Rohner, G, et al.
Published: (2012)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
by: Snape, M, et al.
Published: (2013)